WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 53'7051 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 8'078  7'997  7'915  7'831  7'743  7'166  6'674  6'304 
Births 84  82  81  80  78  76  81  73 
Surviving infants 84  82  81  79  78  76  80  72 
Pop. less than 5 years 406  400  393  384  378  401  385  356 
Pop. less than 15 years 1'193  1'189  1'184  1'179  1'182  1'250  1'137  1'261 
Female 15-49 years 1'923  1'916  1'907  1'896  1'885  1'766  1'719  1'587 

Number of reported case

(Click for retrospective incidence data for Switzerland)
Diphtheria
Japanese encephalitis
Measles 175  61  621  77  958  1'990 
Mumps 140  600  900 
Pertussis 4'700  5'900  3'700 
Polio*
Rubella 10  12  35 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Switzerland)
Vaccine year result method % card seen                                                
BCG         
DTP1          95  95  95 
DTP3          96  96  96  95  95  93  90 
HepB_BD         
HepB3         
Hib3          95  95  95  95  95  91 
JapEnc         
MCV          93  93  93  92  92  82  90 
MCV2          86  86  86  83  83 
PCV1          79 
PCV3          75  75  75  37  37 
Pol3          96  96  96  96  96  95  98 
Rota1         
Rota_last         
Rubella1          91  91  90  86 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Switzerland)
DTP1 98  98  98  95  95  95  96 
DTP3 96  96  96  95  95  93  90 
HepB3
HepB_BD
Hib3 95  95  95  95  95  91 
MCV 93  93  93  92  92  82  90 
MCV2 86  86  86  83  83 
PnC3 75  62  50  37  25 
Pol3 96  96  96  96  96  95  98 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibIPV 2, 4, 6, 15-24 months; Yes
DTaPIPV 4-7 years; Yes
HPV 11-14 years; +6 months; Yes
HepB 11-15 years; +6 months; Yes
Influenza >= 65 years; Yes and risk groups
MMR 12, 15-24 months; Yes
MenC_conj 12-15 months; 11-15 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >= 65 years; Yes
Td 45, >= 65 years; Yes
Tdap 11-15, 25-29 years; Yes
Varicella 11-15 years; +1 month; Yes no anamnestic disease

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2015  2012-2015           
Nº of districts with microplans that include activities to raise immunization coverage number              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number     26  26  26  26  26 
Nº districts with DTP3 coverage >=80% number   22 
% of districts with DTP3 coverage >=80% From 0 to 100%         15 
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100%          

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.